Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by enriquesuave

V.TLT

RE:RE:RE:RE:Great News for Manufacturing and Storage

Storage and manufacturing of Adstiladrin definitely do not compare. ...

September 29, 2023

V.TLT

RE:RE:RE:Great News for Manufacturing and Storage

I think that her job is mainly to attract a Big Pharma for partnership rather...

September 29, 2023

V.TLT

RE:Great News for Manufacturing and Storage

Dr Lbiati Kaouthar independent director was granted 300 000 options yesterday...

September 29, 2023

V.TLT

Great News for Manufacturing and Storage

FDA will like this aspect of long term drug stability.  It can be...

September 29, 2023

V.TLT

RE:Old but relevent GBM news

And. https://stockhouse.com/news/press-releases/2017/09/25/theralase...

September 27, 2023

V.TLT

Old but relevent GBM news

Finally coming to see the light. https://stockhouse.com/news/press...

September 27, 2023

V.TLT

RE:TLT Successfully Completes Non-GLP Toxicity Study for GBM

Nice, this paves the way for a deal with Big Pharma on many more indications...

September 27, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:share price....sigh

A deal would bring enough cash to prevent further dilution and would remove...

September 26, 2023

V.TLT

RE:RE:Bored. Waiting. Here is some playing with data to look at.

Nice chart dawg. For the NR and IR patients, perhaps they can optimize drug...

September 19, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:PP Closed

Yes, what I meant was that not every biotech has the goods worthy of applying...

September 11, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:PP Closed

Bud is lost. There are about 21 000 biotech companies in the world, and only...

September 7, 2023

V.TLT

RE:RE:RE:RE:RE:RE:PP Closed

Out of 1000's of biotechs, there were 251 approvals in 10 years.  ...

September 7, 2023

V.TLT

RE:RE:RE:450 Day CR rate

40-45% CR at 450 days could very well be reached if we also get a few IR...

September 3, 2023

V.TLT

RE:RE:my thoughts and questions

2b7f6fab wrote: Condensing the corn cob down to a kernel.  The loss for...

August 30, 2023

V.TLT

RE:RE:RE:RE:TLT is working with FDA on BTD

Clearly if data was not good enough, I believe the FDA would have stated so...

August 30, 2023

V.TLT

RE:RE:RE:RE:RE:Interim Data...

Pretty stable and awesome data.  270 days is looking better. especially...

August 29, 2023

V.TLT

RE:New Deal for Adstiladrin

Basically paying upfront  $500 Million for 5.1% and up to 8 % of sales...

August 25, 2023

V.TLT

New Deal for Adstiladrin

If they get $500 million for 5.1% Royalties on Adstiladrin we should get...

August 25, 2023

V.TLT

RE:RE:Small correction to table

Could the FDA be considering to give AA for Ruvidar?  BTD is often given...

August 25, 2023

V.TLT

RE:RE:Dr. Black article on Phase 2 Trial of Atezolizumab

Adstiladrin 12 months CR is about 24%. We are beating them badly.  ( 46%...

August 23, 2023

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Hank Payments Corp.

Hank Payments Corp. V.HANK

Hank Payments Corp is an emerging North American leader in the Banking-as-a-Service (BaaS) market. The Hank platform ... view more »